We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Viral DNA Extracted from Histology Specimens

By LabMedica International staff writers
Posted on 02 Aug 2011
DNA from archived formalin-fixed, paraffin-embedded (FFPE) tissues can be used for papillomavirus genotyping, but there are potential problems.

These problems for genotyping of the Human papillomavirus (HPV), include paraffin as a physical barrier, DNA cross-linking, and inhibitors of the polymerase chain reaction (PCR).

Investigators at the US Centers for Disease Control and Prevention (CDC; Atlanta, GA, USA) extracted DNA from 10-μm sections from 150 FFPE cancer samples. More...
They combined a commercially available DNA isolation kit, the DNeasy blood and tissue kit, with a heat treatment and evaluated the resulting DNA with regards to HPV typing. Paraffin was removed by xylene and tissue lysed at 56 °C. A second section was directly incubated at 120 °C and subsequently lysed at 65 °C. After spin-column purification, both extracts were tested with a linear array HPV genotyping assay. Cellular DNA yield, HPV16 DNA copies, and PCR inhibitors were assessed by quantitative real-time PCR (qPCR) assays.

Inadequate linear array HPV genotyping assay results were significantly more frequent in xylene-treated than in heat-treated extracts. HPV detection also differed, with 94/150 (62.7%) positives in the xylene treated and 110/150 (73.3%) positive results in the heat-treated extracts. The heat method also yielded 8.2-fold more PCR-amplifiable cellular DNA and 6.5-fold more HPV16 copies, although PCR inhibitors also had a greater effect.

The DNeasy blood and tissue kit used in the study is a product of Qiagen (Valencia, CA, USA) and some improvements may be due to the increased heat during the proteinase K treatment in the kit, which was previously found more effective for tissue lysis. The improvement might also be due to reversal of formaldehyde-induced cross-linking of nucleic acids through the 120 °C incubation. All qPCR assays were performed in a C1000 thermal cycler with a CFX96 real-time system (Bio-Rad; Hercules, CA, USA). The authors concluded that aggressive heat treatment demonstrated an advantage over traditional xylene purification protocols, resulting in higher DNA yields and increased sensitivity for HPV testing. The study was published on July 4, 2011, in the Journal of Molecular Diagnostics.

Related Links:

US Centers for Disease Control and Prevention
Qiagen



Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Spinal Fluid Cell Count Control
Spinalscopics
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.